Research

Hormonal

Blood pressure control, ACE inhibitor therapy, and statins have proven benefits in reducing cardiovascular risk in Type 2 diabetes.

Healthcare providers should implement these treatments to mitigate cardiovascular risks.

StrongSupportsmedium confidence
Blood pressure control, angiotensin-converting enzyme inhibitor therapy and improvement of dyslipidemia with statins have proven benefit in reducing cardiovascular risk in Type 2 diabetes.
Andrew MN Walker et al. · Expert Review of Endocrinology & Metabolism · 2014

Why this rating

Based on the context of proven benefits.

Source

Contemporary treatment strategies for Type 2 diabetes-related macrovascular disease

Andrew MN Walker et al. · Expert Review of Endocrinology & Metabolism · 2014

reviewCited 1×
Read the paper

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →